112 related articles for article (PubMed ID: 5752690)
21. Experimental epilepsy: a histochemical and ultrastructural study.
Cazzullo CL; Andreola ML; Invernizzi G; Canger R; Giordano F
Arzneimittelforschung; 1973 Apr; 23(4):531-7. PubMed ID: 4740231
[No Abstract] [Full Text] [Related]
22. [Pharmacology of aescin-isomers with special reference to alpha-aescin].
Hampel H; Hofrichter G; Liehn HD; Schlemmer W
Arzneimittelforschung; 1970 Feb; 20(2):209-15. PubMed ID: 5467465
[No Abstract] [Full Text] [Related]
23. [Treatment of postoperative edema with Reparil. Report of experiences (author's transl)].
Otto H; Arfeen N
MMW Munch Med Wochenschr; 1974 May; 116(21):1085-8. PubMed ID: 4209659
[No Abstract] [Full Text] [Related]
24. [Experimental and clinical testing of an aescin and heparinoid containing gel].
Mittelstaedt R
Cosmetologica; 1970 May; 19(5):167-70. PubMed ID: 4099966
[No Abstract] [Full Text] [Related]
25. [On the effect of aescin and flavonoid complex from horse chestnut on inflammatory edema].
Obolentseva GV; Khadzhaĭ IaI
Farmakol Toksikol; 1969; 32(2):174-7. PubMed ID: 5814379
[No Abstract] [Full Text] [Related]
26. [Therapeutic effects of Reparil. Clinical experimental studies and therapeutic observations].
Steinacher J
Z Haut Geschlechtskr; 1972 Jul; 47(13):559-64. PubMed ID: 4569258
[No Abstract] [Full Text] [Related]
27. [Effects of aescin on the breast engorgement].
Ardillo L; Zen L
Attual Ostet Ginecol; 1969; 15(2):79-83. PubMed ID: 5408632
[No Abstract] [Full Text] [Related]
28. [Aescin in ambulant and stationary orthopedic patients].
Kienzler G
Med Welt; 1968 Aug; 32():1740-3. PubMed ID: 5752776
[No Abstract] [Full Text] [Related]
29. [Intensive therapy of gestoses. Our experience in the years 1969-1971].
Ferrero A; Marzullo C; Salmoiraghi ML
Ann Ostet Ginecol Med Perinat; 1971 Dec; 92(12):901-7. PubMed ID: 5004840
[No Abstract] [Full Text] [Related]
30. [Wound healing of episiotomies during follow-up therapy using aescin].
Tillmanns H; Pförtner P
Munch Med Wochenschr; 1969 Nov; 111(46):2410-2. PubMed ID: 5394827
[No Abstract] [Full Text] [Related]
31. [Aescin (=Reparil) in cerebral circulation disorders. Clinical and ophthalmodynamographic observations].
Tzavellas O; Finke J
Wien Klin Wochenschr; 1970 Oct; 82(41):714-6. PubMed ID: 5529668
[No Abstract] [Full Text] [Related]
32. [Modern treatment of cerebral edema].
Iwanowski L; Jedrzejewska A; Dobosz I
Pol Tyg Lek; 1970 Jul; 25(28):1064-7. PubMed ID: 4916000
[No Abstract] [Full Text] [Related]
33. [Experiences with Reparil in surgical diseases].
Stock M
Med Welt; 1971 Jun; 22(25):1057-9. PubMed ID: 5104409
[No Abstract] [Full Text] [Related]
34. [Studies on the effect of dexamethasone on the dema inhibitory effect of aescin].
Lippert TH; Weinberg K
Arzneimittelforschung; 1967 Dec; 17(12):1598-9. PubMed ID: 5632807
[No Abstract] [Full Text] [Related]
35. [Experimental studies on the effectiveness of aescin "Reparil" in Parkinson patients].
Tzavellas O
Wien Klin Wochenschr; 1968 Jan; 80(2):30-4. PubMed ID: 5691318
[No Abstract] [Full Text] [Related]
36. Effect of VEGF receptor antagonist (VGA1155) on brain edema in the rat cold injury model.
Koyama J; Miyake S; Sasayama T; Kondoh T; Kohmura E
Kobe J Med Sci; 2007; 53(5):199-207. PubMed ID: 18204296
[TBL] [Abstract][Full Text] [Related]
37. Quantitative autoradiographic studies of brain edema and a comparison of multi-isotope autoradiographic techniques.
Blasberg RG; Gazendam J; Patlak CS; Fenstermacher JD
Adv Neurol; 1980; 28():255-70. PubMed ID: 7457244
[No Abstract] [Full Text] [Related]
38. [Therapeutic effect of glucose-6-phosphate polyclonal antibody on vasogenic brain edema in rats].
Tao Z; Lu BX; Zhang YZ; Cheng G
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1041-3. PubMed ID: 16864109
[TBL] [Abstract][Full Text] [Related]
39. [Enteral resorption of aescin].
Meyer-Bertenrath J; Kaffarnik H
Arzneimittelforschung; 1970 Jan; 20(1):147-8. PubMed ID: 5467438
[No Abstract] [Full Text] [Related]
40. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia.
Sato T; Morishima Y; Shirasaki Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1042-7. PubMed ID: 12604680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
